On 22 March 2006, a 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device. The implant was conducted at the Vienna General Hospital and the surgical team was led by Dr Georg Wieselthaler, Clinical Director of Mechanical Circulatory Support at the University of Vienna.
Eastland Medical Systems Ltd (Eastland) is pleased to announce the completion of their newly designed tooling for the production of their speciality safety syringe Retralok.
Leading cell therapy services company CyGenics Ltd. (ASX: CYN) announced that its US-based subsidiary, Cytomatrix LLC, had been granted US Patent 6991933, Cell Culture Spinner Flasks. This patent adds to the five already granted to the CyGenics group. A number of other patents are pending.
Eastland Medical Systems (ASX: EMS) is now nearing completion of commercial tooling for production of its ClipOn "Safe" needle device. Production is scheduled to commence in mid February 2006 at Eastland's Portland facility in Victoria and shipments for hospital trials in Australia, South Africa and the United Kingdom will follow shortly thereafter.
Friday 23 December 2005: Clinical Cell Culture Ltd (C3, ASX: CCE) Clinical Cell Culture (ASX: CCE) would like to clarify aspects of its application for approval to sell its ReCell tissue engineering device in Australia following media comments by the Therapeutic Goods Administration (TGA).
Ritract Limited is pleased to announce that it has signed a Letter of Intent with the Verna Group to sell and distribute Ritract products in the United Kingdom and Ireland under the well-established Vernacare brand.
The BRM 2 Brain Monitor is a portable bedside electroencephalograph (EEG) that can be used to detect changes and abnormalities in the cerebral function of patients in Neonatal and Paediatric Intensive Care Units.
